Illumina (ILMN) Tops Q2 EPS by 8c, Beats on Revenue; Offers FY26 Guidance

Illumina (NASDAQ: ILMN) reported Q2 EPS of $1.31, $0.08 better than the analyst estimate of $1.23. Revenue for the quarter came in at $1.16 billion versus the consensus estimate of $1.13 billion.

GUIDANCE:

Illumina sees FY2026 EPS of $5.30-$5.40, versus the consensus of $5.23. Illumina sees FY2026 revenue of $4.6-4.64 billion, versus the consensus of $4.57 billion.

For earnings history and earnings-related data on Illumina (ILMN) click here.

You May Also Be Interested In

• Westinghouse said to seek over $50 billion valuation in planned IPO
• Anthropic expects over $100B in annualized revenue this year - Bloomberg
• Dianthus Therapeutics (DNTH) files mixed shelf